Recent Updates
Recently added Catalysts
BAX Positive Sentiment

Baxter to Host Third-Quarter 2026 Financial Results Conference Call for Investors

Wednesday, October 7, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Baxter International Inc. will host a conference call on October 29, 2026, to discuss its third-quarter financial results. The call is scheduled for 7:30 a.m. Central Time and will be accessible through pre-registration. Additionally, it will be webcasted on Baxter's official website, allowing broader investor engagement.

Market Sentiment Analysis

POSITIVE FACTORS

  • Baxter is actively engaging with investors.
  • The conference call provides transparency on financial performance.
  • The event is accessible via webcast, enhancing participation.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+71%
120-day peak, hindsight
Typical move
2.1%
average across 13 past catalysts
Lead asset
Glycerophosphate
Phase 1 · Parenteral Nutrition

Full Press Release Details

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2026 financial results on Thursday, October 29, 2026, at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://events.q4inc.com/analyst/129835310?pwd=2FG2j7ZZ to pre-register for the call and receive the call information.This call is also being webcast and can be accessed through Baxter’s website at www.

Frequently Asked Questions

When is Baxter's Q3 2026 financial results call?

The call is scheduled for October 29, 2026, at 7:30 a.m. Central Time.

How can I participate in the conference call?

You can pre-register for the call via the provided link to receive call information.

Will the call be available for online viewing?

Yes, the conference call will also be webcasted on Baxter's website.

What is the purpose of the conference call?

The call aims to discuss Baxter's third-quarter 2026 financial results.

ShareAdd on Google
Tags: BAX Baxter International financial results conference call investors
Last updated: Oct 7, 2026

Biotech snapshot

Cash runway
$2150M liquidity · $0M/mo burn
Low dilution risk
Lead asset
GlycerophosphatePhase 1
Parenteral Nutrition →

Catalyst track record

+71%
best trade around BAX's most recent catalyst

Peak hindsight return over a 120-day window, across 13 tracked FDA/PDUFA catalysts for BAX.

See every catalyst's timing & PoA →